Alex Sherman, Massachusetts General Hospital to Speak at GTCbio’s Big Data Bioinformatics
Alex Sherman at Massachusetts General Hospital will discuss, “Big Data in Rare Diseases” at GTCbio’s Big Data Bioinformatics conference.
Boston, MA, March 10, 2016 --(PR.com)-- Alex's interests and passion are in developing collaborations in clinical research and building disease-specific research networks and consortia to achieve “Big Data” in rare diseases.
Alex has 30+ years of experience in research, software development, software architecture, expert systems design, clinical trials systems design, data management and clinical trials management. As the Director of Strategic Development and Systems at the Neurological Clinical Research Institute (NCRI), Mr. Sherman is responsible for the successful design, development and deployment of software systems for numerous clinical trials and biomarker studies in ALS, Huntington’s disease, Parkinson’s disease, stroke and depression. Alex conceived and was instrumental in design, development and adoption by the international research community of NeuroBANK™, an accelerated clinical research platform, and ALSBANK™ platform, a virtual distributed biorepository currently utilized by numerous researchers and institutions. His team was responsible for design and implementation of PRO-ACT project that created the largest clinical dataset in ALS (10,700+ subjects) and is the de-facto reference dataset in ALS research. This platform was selected as the Best Bio-IT project of 2013 by the Bio-IT World Congress. Alex served on the NINDS Common Data Elements committee, is the Chair of the NeuroBANK™ committee of NEALS and is a Board Member of the ALS Research Group (ALSRG) and ALD Connect consortium. Mr. Sherman holds Masters of Science degree in Nuclear Engineering and graduated from a doctorate program in Nuclear Engineering. He is a Principal Associate in Neurology at Harvard Medical School.
He is a frequent speaker at academic and industry conferences and has many publications on the topics of collaboration in clinical research, data and biospecimen sharing and technology utilization for these purposes and will be speaking at GTCbio Big Data Bioinformatics conference, to be held on May 26th -27th 2016 in Boston, MA.
GTCbio's Big Data Bioinformatics conference provides cutting-edge information on developments in all areas of Bioinformatics research and novel Big Data analytic approaches.
This conference is also part of the larger Genomics & Big Data Summit, which consists of three additional conferences including this meeting:
6th Next Generation Sequencing
3rd Metabolomics - Advances & Applications in Human Disease Conference
CRISPR & Genome Engineering
Big Data Bioinformatics
For more information please visit website: www.gtcbio.com/big-data
GTCbio
635 W. Foothill Blvd
Monrovia, CA 91016
www.gtcbio.com/
Email: infogtcbio@gtcbio.com
Phone: (626) 256-6405
Fax: (626) 466-4433
Alex has 30+ years of experience in research, software development, software architecture, expert systems design, clinical trials systems design, data management and clinical trials management. As the Director of Strategic Development and Systems at the Neurological Clinical Research Institute (NCRI), Mr. Sherman is responsible for the successful design, development and deployment of software systems for numerous clinical trials and biomarker studies in ALS, Huntington’s disease, Parkinson’s disease, stroke and depression. Alex conceived and was instrumental in design, development and adoption by the international research community of NeuroBANK™, an accelerated clinical research platform, and ALSBANK™ platform, a virtual distributed biorepository currently utilized by numerous researchers and institutions. His team was responsible for design and implementation of PRO-ACT project that created the largest clinical dataset in ALS (10,700+ subjects) and is the de-facto reference dataset in ALS research. This platform was selected as the Best Bio-IT project of 2013 by the Bio-IT World Congress. Alex served on the NINDS Common Data Elements committee, is the Chair of the NeuroBANK™ committee of NEALS and is a Board Member of the ALS Research Group (ALSRG) and ALD Connect consortium. Mr. Sherman holds Masters of Science degree in Nuclear Engineering and graduated from a doctorate program in Nuclear Engineering. He is a Principal Associate in Neurology at Harvard Medical School.
He is a frequent speaker at academic and industry conferences and has many publications on the topics of collaboration in clinical research, data and biospecimen sharing and technology utilization for these purposes and will be speaking at GTCbio Big Data Bioinformatics conference, to be held on May 26th -27th 2016 in Boston, MA.
GTCbio's Big Data Bioinformatics conference provides cutting-edge information on developments in all areas of Bioinformatics research and novel Big Data analytic approaches.
This conference is also part of the larger Genomics & Big Data Summit, which consists of three additional conferences including this meeting:
6th Next Generation Sequencing
3rd Metabolomics - Advances & Applications in Human Disease Conference
CRISPR & Genome Engineering
Big Data Bioinformatics
For more information please visit website: www.gtcbio.com/big-data
GTCbio
635 W. Foothill Blvd
Monrovia, CA 91016
www.gtcbio.com/
Email: infogtcbio@gtcbio.com
Phone: (626) 256-6405
Fax: (626) 466-4433
Contact
GTCbio
Kristen Starkey
626-256-6405
http://www.gtcbio.com
635 W. Foothill Blvd.
Monrovia, CA 91016
fax: 626-466-4433
Kristen Starkey
626-256-6405
http://www.gtcbio.com
635 W. Foothill Blvd.
Monrovia, CA 91016
fax: 626-466-4433
Contact
Categories